학술논문
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial
Document Type
Article
Author
Source
In: BMC Cancer . (BMC Cancer, December 2023, 23(1))
Subject
Language
English
ISSN
14712407